Weight Reduction study: Family Diabetes Prevention
Official title Georgia CEAL RESTORES Family Diabetes Study
ClinicalTrials.gov ID: NCT07808723
What this study is testing
- What it's testing
- The study will see if a family‑focused diet and activity program can reduce the chance of developing type 2 diabetes and promote weight loss and healthier habits.
- Who it's for
- Parents who are overweight or have prediabetes and their children.
- What's involved
- Participants will join a 12‑week program that includes diet and exercise guidance, regular group or virtual sessions, and weight and lifestyle check‑ins.
- Time commitment
- The study lasts about 12 weeks with weekly visits and a follow‑up check‑in three months after the program ends.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older. Healthy volunteers may be eligible.
You may be able to join if
- Parent/guardian must identify as African American or Hispanic
- Parent/guardian must be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child)
- Parent/guardian must have prediabetes (HbA1c level 5.7-6.4%) or be at risk of developing Type 2 diabetes using CDC's Pre-Diabetes Risk Test
- Participant is willing to commit to participation in a 12-week, in-person, intervention study
- No plans to move over the next 9-months
You likely can't join if
- Severe psychological disorders that may prevent/interfere with study -participation
- Physical impairments that may prevent participation in moderate intensity physical activity
- Previous diagnosis of diabetes
- History of congestive heart failure
- Renal failure
- Recent (\<12 months) cardiovascular events such as myocardial infarction (heart attack) or stroke
See the full eligibility criteria
- Parent/guardian must identify as African American or Hispanic
- Parent/guardian must be 18+ years residing in the same household as the child (i.e., biological or have legal guardianship for child)
- Parent/guardian must have prediabetes (HbA1c level 5.7-6.4%) or be at risk of developing Type 2 diabetes using CDC's Pre-Diabetes Risk Test
- Participant is willing to commit to participation in a 12-week, in-person, intervention study
- No plans to move over the next 9-months
- Parent/guardian should be ambulatory and able to participate in physical activity
- Children must be between the ages of 12-17 years old
- Child should be ambulatory and able to participate in physical activity
- Severe psychological disorders that may prevent/interfere with study -participation
- Physical impairments that may prevent participation in moderate intensity physical activity
- Previous diagnosis of diabetes
- History of congestive heart failure
- Renal failure
- Recent (\<12 months) cardiovascular events such as myocardial infarction (heart attack) or stroke
- Taking medications that may affect endpoint analyses
- Have co-morbid contraindications to physical activity or dietary changes
- Currently pregnant or planning to become pregnant in the next year
- Family lives outside of Georgia
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.